Auto Amazon Links: No products found.
Starting from 31 July, a new meningitis B (MenB) vaccination program will be introduced for young people and university students in Northern Ireland, according to the region’s chief medical officer. This initiative comes in response to a meningitis outbreak earlier this year in England, where tragically two individuals—a university student and a sixth-form pupil—lost their lives. The vaccination involves two doses and is aimed at those considered most vulnerable to the infection, including Year 14 pupils and first-time university or higher education students under the age of 25 who will be starting this autumn.
MenB is a serious bacterial infection known for causing life-threatening illnesses such as inflammation of the membranes around the brain and blood poisoning (sepsis). It spreads primarily through close personal contact, like kissing or sharing items such as vapes or drinks, and is particularly risky in settings where people live in close proximity, such as student dormitories. Similar vaccination efforts are underway across other parts of the UK, including England, Wales, and Scotland.
Eligibility for the vaccine in Northern Ireland is clearly defined in a letter from Chief Medical Officer Prof Sir Michael McBride. Those eligible include individuals born between 2 July 2007 and 1 July 2008, and those born on or after 21 July 2001 who are due to begin an undergraduate degree in the UK or Ireland this autumn, including international students. It also covers those entering university or further education halls of residence for the first time this autumn. Students who are not in Year 14 during the 2025/2026 academic year, postgraduate students, or those not starting university for the first time this autumn are excluded from the program. The vaccine requires two doses given approximately 28 days apart for maximum protection, and it is encouraged that both doses be completed prior to starting university.
Young people are particularly encouraged to receive the MenB vaccine because university life brings them into close contact with many new people in communal living spaces, social settings, and shared facilities, which increases the risk of infection. Following a surge of cases and changes in recommendations from the Joint Committee on Vaccination and Immunisation (JCVI), health experts are advocating for a broader vaccination campaign for all teenagers from age 15. The Department of Health in Northern Ireland has indicated that they are considering whether to extend the vaccine rollout accordingly, with a policy decision expected in due course. The first doses will be available until 31 December 2026, with the second doses offered until 31 March 2027 to accommodate late arrivals and international students.
While meningitis can affect adults, especially those with compromised immune systems, the highest risks are among children and young people. The Public Health Agency and the Department of Health have yet to announce specifics on where or how the vaccine will be administered, but a “mixed delivery model” is planned, involving GPs, community pharmacies, and vaccination clinics on university campuses. This approach aims to make access to the vaccine as convenient as possible for those eligible
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found.